Name

Ibru­ti­nib

Syn­onyms

AccordingtoLuimatinib;2-Propen-1-one,1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-;(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo-[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-;PCI-32765;1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one ;PCI-32765(Ibrutinib);(R)-1-(3-(4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl)piperidin-1-yl)prop-2-en-1-one;1-[(3R)-3-[4-AMino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyriMidin-1-yl]piperidin-1-yl]prop-2-en-1-one

Mol­e­c­u­lar Formula

C25H24N6O2

Mol­e­c­u­lar Weight

440.5

CAS Num­ber (Or Wat­son Num­ber for Non-CAS Products)

936563-96-1

EINECS

1308068-626-2

Appear­ance

Specs/​Standards

Enter­prise Stan­dard

Use

Links

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd (http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing link http://​cam​ing​.com/​I​b​r​u​t​i​n​i​b​-​c​a​s​-​9​3​6​5​6​3​-​9​6​-1/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly. 

























    Please prove you are human by select­ing the key.




    Dis­claimer

    This prod­uct is for research and devel­op­ment pur­pose only which may not be used direct­ly as drugs, food, cos­met­ics or for any oth­er non-R&D pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.